Compounded tirzepatide: who sells it, and who will tell you who makes it

In its favour

• Flat $149/month that stays the same across every dose level — no escalation surcharge as you titrate up
• Doctor-reviewed protocols filled by a 503A compounding pharmacy
• Included 1:1 support from nurses and registered dietitians
• Automatic refund if you are not approved for treatment

Against it

• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound) — see our evidence guide
• Single-medication focus rather than a broad telehealth catalog

In its favour

• Unusually broad compounded menu under one roof — injectable and oral tirzepatide plus semaglutide, with NAD+, sermorelin, and TRT alongside
• Transparent, low headline tirzepatide pricing ($169/month injectable) with no insurance required and Klarna/Affirm financing
• Rare oral tirzepatide-drops pathway for patients who want to avoid injections
• 100% online with licensed-clinician review, discreet delivery, and clear upfront compounded/not-FDA disclaimers

Against it

• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound) — quality depends on the partner pharmacies
• Oral tirzepatide drops lack the robust absorption and efficacy evidence of injectables
• No published list of states served and no named legal entity or medical group — a transparency gap
• Advertised prices are floors finalized after clinical review, and the very broad storefront has a thin public track record

In its favour

• Established since 2019 and sizable (250k+ members), with obesity-medicine clinicians — a longer track record than most compounded-only startups
• Broad formulary including the real FDA-approved brand-name products (Zepbound and Mounjaro), not only compounded tirzepatide
• Behavioral coaching, app, and member community paired with the medication
• Insurance navigation plus HSA/FSA accepted, available in all 50 states

Against it

• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• Layered pricing — the cheapest compounded rate requires a 3–12 month prepay
• The brand-name pathway stacks a separate membership fee (about $39/month) on top of the medication
• Cost and coverage vary by state and plan, so there is no single flat monthly figure

In its favour

• Low compounded entry at $179/month with all doses included, so titrating up costs nothing extra
• Available in all 50 states — broader coverage than most compounded-only startups
• Offers a brand-name pathway (Ozempic) alongside compounded options
• LegitScript-certified, with HRT and menopause care under the same roof

Against it

• The $179 headline requires a YEARLY subscription — no month-to-month price is published anywhere on the site
• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• The $149 microdose tier is sub-therapeutic and should not be read as a cheap tirzepatide dose
• The brand-name Ozempic option is very expensive at $1,299, and the dispensing pharmacy is never named

In its favour

• Publishes its full four-tier price ladder openly, with the billed total next to each per-month figure — rare candour in this category
• Flat price at every dose, so titration never raises the bill
• One membership covers the visit, medication and free overnight shipping to all 50 states
• Buy-now-pay-later (Affirm / Klarna / Afterpay) available on the prepaid terms

Against it

• The $125 headline needs $1,500 paid up front; month-to-month is $235, more than CoreAge's flat $149
• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• Prepaying a year for a medication you may not tolerate carries real refund risk
• Injectable only — no oral or brand-name pathway

In its favour

• Transparent, published tiered pricing including microdose and a sema+tirz combination
• Dose-flat within each tier — no surcharge as you titrate up
• Included provider care and 6-month lab testing
• NAD+ available as an adjacent longevity offering

Against it

• Compounded only — no FDA-approved brand or oral tirzepatide pathway
• Higher entry price ($280/month standard tirzepatide) than CoreAge's flat $149
• States served are not published on the site
• The standard tier costs more than several rivals for the same molecule

In its favour

• Transparent, publicly listed pricing on the site — many compounded competitors hide the price behind a quiz
• Both semaglutide and tirzepatide (not single-drug), plus a broad menu — NAD+, microdosing, and an optional coaching/nutritionist/labs bundle
• Markets 50-state clinician access with no insurance required and HSA/FSA accepted

Against it

• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound), and compounding availability can tighten as brand shortages resolve
• Mid-market pricing at $299/month — above the cheapest compounders (~$99–$150)
• No brand-name and no oral pathway — injectable only
• Thin independent footprint with few third-party reviews; the 50-state and efficacy claims are self-reported

In its favour

• Multiple tirzepatide formats — compounded injectable, oral, and microdosed — a rare combination in one program
• LegitScript-certified and HIPAA-compliant, with U.S. providers and licensed pharmacies
• Low published entry price on annual plans (from $99/month tirzepatide; from $49/month microdosed), with HSA/FSA accepted and free 48-hour shipping
• Broad catalog beyond GLP-1 (semaglutide, PT-141, intranasal NAD+, recovery peptides, HRT)

Against it

• Every formulation is compounded — not the FDA-approved branded product (Mounjaro / Zepbound)
• The lowest headline prices require a 6- to 12-month commitment; short plans run $145/$199/$399 for the first month
• Pricing is opaque outside the GLP-1 menu, and the list of states served is not published
• No named clinicians and thin third-party reviews

In its favour

• Rare oral/sublingual tirzepatide option in addition to injectable
• All-inclusive pricing with no separate membership fee
• Offers both tirzepatide and semaglutide molecules

Against it

• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• Pricing is company-stated and could not be independently verified on a live page
• Newer operator (2024) with an ambiguous footprint across multiple domains
• States served are not disclosed

In its favour

• LegitScript-certified (#50087439) — a genuine third-party trust signal most compounded providers lack
• Physician-supervised, with a licensed U.S. 503A compounding pharmacy
• Offers tirzepatide, semaglutide, and a rare oral GLP tablet alongside injectable
• Transparent monthly pricing with no insurance required

Against it

• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• Several tiers are company-stated and could not be independently verified on a live public page
• Brand tiers are an expensive pass-through (~$1,299)
• Number of states served is not published

In its favour

• LegitScript-certified — a genuine third-party trust signal many compounded startups lack
• Offers a real brand-name Wegovy/Zepbound pathway alongside compounded tirzepatide, uncommon for a low-cost compounder
• Transparent compounded pricing from $199/month tirzepatide (compounded semaglutide from $149/month)
• Low-friction signup — often no labs and no separate video visit required

Against it

• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• No named medical director, and the low-friction model (often no labs or visit) means thinner clinical oversight
• Injectable only — no oral tirzepatide pathway
• State availability is quiz-gated rather than published, and $199/month is above the cheapest flat compounders

In its favour

• Value-priced compounded tirzepatide bundles — $139/month on the 12-month plan (from $209 the first month), undercutting most mid-market compounders
• Transparent GLP-1 pricing shown publicly on the site, with compounded semaglutide also from $139/month
• Backed by the recognizable Bodybuilding.com brand and a broad menu (NAD+, sermorelin, ED, peptides) under one login
• Standard telehealth flow: online intake reviewed by an independent licensed provider, free until you are approved

Against it

• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• Brand-new operator (Dynamo Group LLC, launched ~April 2026) with a thin, mixed third-party review record
• Lowest prices require a large upfront prepay, and prescription products are final sale — no refunds for change of mind or results
• Pharmacy and provider network are not named on the consumer pages, and we could not verify a LegitScript certification

In its favour

• Four routes to the same molecule — injection, liquid drops and lozenges compounded, plus brand Zepbound if you want the FDA-approved product
• Unlimited follow-up appointments and health coaching included with membership
• A published 120-day weight-loss guarantee, which almost nothing else in this ranking offers
• GLP-1 treatment available in all 50 states

Against it

• At $299/month month-to-month it costs twice CoreAge's flat $149 for the same molecule; reaching $239 means committing to twelve months up front
• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• The advertised "as low as $239" is a twelve-month commitment rate — the month-to-month price is $299
• The dispensing compounding pharmacy is not publicly named

In its favour

• A low flat $185/month at every dose
• One price across every dose, so titrating up does not raise the monthly cost
• No membership or subscription fee, and free shipping
• All 50 states, with the process available in Spanish as well as English

Against it

• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• Same-day approval with no video call means very little clinical contact before a prescription
• Sold as packages, so continuity is on you to re-order rather than arriving automatically
• No brand-name pathway and no oral or sublingual route

In its favour

• Sublingual tirzepatide lozenges at the same price as the injection, so the needle is optional without paying a premium for it
• Free physician visit, free shipping and free follow-up care included in the price
• Subscriptions can be cancelled, paused or delayed yourself with 48 hours' notice
• Every route and price is published on the product page rather than hidden behind an intake

Against it

• At $199/month it costs more than CoreAge's flat $149 for the same molecule
• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• Asynchronous by design — in many states you will never speak to the prescriber
• Not available in Arkansas

In its favour

• One flat price at every dose, published dose by dose from 2.5mg to 15mg
• LegitScript verified, with board-certified physician review and U.S. compounding pharmacies
• Refund of everything but a $39 visit fee if you are not prescribed — stated up front, not buried
• Free overnight shipping with injection supplies included, and an oral tirzepatide route if you want it

Against it

• The most expensive tirzepatide in this ranking at $399/month quarterly — well above CoreAge's flat $149
• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• Available in 40 states rather than nationwide, so check yours before starting
• Ships one vial every two months, a less flexible cadence than a monthly refill

In its favour

• Will prescribe brand-name Mounjaro when clinically appropriate — genuine FDA-approved tirzepatide, not only compounded
• Unlimited appointments, messaging and 24/7 access to a dedicated clinical team
• FSA and HSA eligible

Against it

• No GLP-1 price anywhere on the public site — it prices its longevity line openly but not the medication this page is about
• At $349/month it sits near the top of this ranking, roughly $100 above the compounded tirzepatide median
• Does not publish which states it serves
• No published cancellation or refund terms
• The weakest conversion record of any programme in this ranking, which usually tracks with a rough purchase experience

In its favour

• Oral tirzepatide as well as injectable — one of very few programmes here offering the molecule without a needle
• LegitScript certified and HIPAA compliant, with a real brand pathway (Ozempic, Rybelsus) beside the compounded line
• One platform if you also want hair, TRT, sexual health or NAD+ handled in the same place

Against it

• No tirzepatide-specific price at all — the advertised $199 is a shared weight-loss starting figure across molecules
• Per-dose pricing is quiz-gated, so you cannot model a titrated monthly cost before entering the intake
• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• No named clinicians, founding year or parent company disclosed, so transparency on who is behind it is thin

In its favour

• Nothing is charged until a provider approves you, and the consult is free if you go ahead
• One inclusive price covering consult, medication, supplies, shipping and support
• LegitScript certified, and available in all 50 states
• Cancel or change plan at any time, stated in the funnel rather than buried in terms
• NAD+ injections offered alongside the GLP-1 line if you want both from one provider

Against it

• Every quoted figure is for the LOWEST dose — the funnel states higher doses may cost more, so $299 is a floor, not the price of a titrated dose
• No tirzepatide price is published anywhere on the public site; you must complete an intake to see it
• At $299–$399/month it is well above CoreAge's flat $149 for the same molecule
• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• An $80 consultation fee applies if you are approved and then decide not to proceed

In its favour

• Unlimited access to a physician and registered dietitian, plus nutrition coaching
• Compounded injectable tirzepatide available with flexible 1-, 3-, 6-, and 12-month terms

Against it

• Stacked cost: the $79/month membership is charged on top of the $199/month medication
• The membership renews after the promotional first month, raising the true monthly total
• Total monthly outlay runs well above CoreAge's flat $149 once the membership renews

In its favour

• Entirely online with free shipping and a broad telehealth catalog
• Low promotional membership price for the first month

Against it

• Stacked cost: the membership ($99/month after the first month) is charged on top of the $199/month medication
• Membership is required to access a prescription and does not guarantee one
• Total monthly outlay can exceed CoreAge once the membership renews

In its favour

• Single all-in monthly fee with no separate membership stacked on top
• Provider visit, medication, supplies, ongoing care, and shipping included in the quoted price

Against it

• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• Quoted price is a starting figure that rises with higher doses and certain plans
• Compounded GLP-1 programs operate in a contracting, enforcement-heavy regulatory space post-shortage

In its favour

• Flat pricing across every dose — titrating up to a therapeutic dose does not raise the bill
• Both compounded tirzepatide and compounded semaglutide on one account
• Available in all 50 states
• A published price ladder you can read before starting an intake, which is rarer in this category than it should be

Against it

• The advertised $139 requires paying $1,668 for twelve months up front; month-to-month is $179
• Compounded tirzepatide is not the FDA-approved branded product (Mounjaro / Zepbound)
• The microdose line's 'limited time' strike-through pricing has persisted long enough that it reads as regular pricing
• Very little published detail about the clinicians or the compounding pharmacy behind the prescription

In its favour

• Names its 503A compounding pharmacies — Belmar, Strive, Epiq Scripts and Casa Pharma — rather than referring vaguely to 'US-licensed pharmacies'
• LegitScript certified, with the certificate number published (#50405601)
• Physician-founded and openly attributed, which is unusual in compounded telehealth
• A real brand-name pathway (Zepbound, Wegovy, Ozempic) alongside the compounded tiers, so you are not forced into a copy
• Ships to all 50 states, with expedited shipping and 24/7 support included in the price

Against it

• At $329/month month-to-month the compounded injection is well above the cheapest programs on this board
• Brand-name pricing is high even by brand standards — Zepbound $1,069, Ozempic $1,299, Wegovy $1,349
• The oral capsule tier costs more than the injection while having no published evidence that it absorbs
• A multi-vertical practice (hair, sexual health, longevity) rather than a weight-management specialist
• The operating legal entity is not published on the site

In its favour

• A genuine price lock — the $299 base rate is contractually held as your dose escalates, not just advertised as flat
• LegitScript certified, with a clear Section 503A compounding disclosure on every landing page
• Unlimited clinician messaging and 24/7 care-team access folded into the single price
• Fast path from intake to delivery — roughly five minutes to apply, 24 hours to a prescription, two to four days to the door

Against it

• Incorporated in May 2024, so there is very little operating history to judge it on
• Not BBB accredited, carrying a C+ rating with complaints concentrated on shipping delays and support access
• Compounding pharmacy partners are not named, so the 503A claim cannot be independently checked
• Compounded only — no path to FDA-approved Zepbound or Mounjaro if you decide you want the brand
• Per-drug tier pricing sits behind the intake quiz

In its favour

• Genuinely flat across the whole dose range, 2.5 mg through 15 mg, with medication, consults, nutrition coaching and 24/7 support in one figure
• Injectable and oral formats are priced the same rather than the oral carrying a premium
• Available in all 50 states plus Puerto Rico
• A full refund is available if you are disqualified at medical review, stated in the terms rather than implied

Against it

• You pay before a clinician reviews you — the refund tiers in its own terms establish that ordering, and there is no refund once a prescription is transmitted
• No third-party pharmacy accreditation (no LegitScript, PCAB, ACHC or NABP) and no named pharmacy partner
• BBB rating of B, not accredited, with complaints up to 14 and centred on billing and cancellation
• Compounded only — no FDA-approved Zepbound or Mounjaro option
• The $167 headline needs $1,999 paid twelve months in advance

In its favour

• Flat across dose tiers with an explicit commitment not to raise the rate mid-programme
• Free shipping with monthly delivery, and dispatch as soon as the next day
• Both compounded semaglutide and compounded tirzepatide, plus a brand-name path
• A 24/7 patient portal, with HIPAA, privacy, SMS and terms policies all published

Against it

• Bundle pricing that used to be public is now gated behind the intake quiz
• Asynchronous questionnaire intake with no mandatory video visit before prescribing
• The compounding pharmacy partner is not named and the state-availability list is not published
• No LegitScript certification displayed
• Brand-name Mounjaro and Zepbound are listed from $1,249/month — far above LillyDirect self-pay vials

In its favour

• Names its dispensing pharmacies (Beaker and Red Rock) in its terms rather than referring to unnamed 'US-licensed pharmacies'
• Publishes the FDA compounded-medication disclaimer with explicit 503A and 503B facility references
• The brand-name path is a transparent referral — a $100 consult, then LillyDirect bills the drug at its own price
• Microdosing protocols offered for both compounded semaglutide and compounded tirzepatide
• One account covers GLP-1, TRT and peptides if you want them from a single provider

Against it

• The $289 appears only inside a pricing-comparison image — the tirzepatide landing page's text contains no dollar figures at all
• The ongoing rate after the first plan period is not published and is gated behind the application flow
• Brand-name Zepbound carries a $100 consult fee on top of whatever LillyDirect charges
• No LegitScript certification mentioned, and no named medical director
• Not available in three states

In its favour

• Four compounded formats on one menu — semaglutide and tirzepatide, injectable or oral dissolving tablet
• Board-certified obesity specialists conducting the virtual consultations
• Available in 49 states, broader than most compounded GLP-1 programmes
• The standing rate is published rather than only the discounted first month, so the step-up is visible before you commit
• 24/7 support with a dedicated phone line

Against it

• At $349/month standing it is one of the more expensive compounded options on this board
• The oral dissolving tablet is priced the same as the injection despite no published evidence that it absorbs
• Not available in Louisiana
• No visible LegitScript certification or PCAB accreditation, and the pharmacy partner is not named
• Full pricing is not shown until the intake quiz is completed

In its favour

• Entry pricing published openly on the public site rather than gated — tirzepatide $297, injectable semaglutide $197, oral semaglutide $198
• A genuine longevity stack (NAD+, sermorelin, enclomiphene, DNA panel) if you want more than a GLP-1 from one provider
• Both injectable and oral compounded semaglutide, where most programmes carry one

Against it

• $297/month is above the median for compounded tirzepatide, and multi-month pricing is not published before the quiz
• The states served are not listed anywhere on the public site
• The pharmacy partner is not named beyond a Springville, Utah fulfilment reference
• Compounded only — no route to FDA-approved Zepbound or Mounjaro
• A very broad catalogue for a small platform, which raises the question of depth on any one line

In its favour

• All 50 states plus DC — the broadest coverage on this board
• Flat rate across every dose tier, so climbing the ladder does not change the price
• A defined microdose protocol for people with less weight to lose, rather than microdosing as an afterthought
• An established brand with a real operating history, unusual among compounded GLP-1 sellers

Against it

• Third-party reviewers report an F rating at the BBB, with complaints about prescriptions that were never fulfilled
• No LegitScript or PCAB certification found
• At $359.99 month-to-month it is among the most expensive compounded tirzepatide on this board; $240 needs a twelve-month commitment
• GLP-1 is a secondary line — testosterone therapy is the core business
• Compounded tirzepatide is not the FDA-approved branded product

In its favour

• Flat pricing across semaglutide dose tiers from 0.25 mg to 2.4 mg, at a genuinely low $105/month
• Month-to-month cancellation through the patient portal with no cancellation fee
• Covers the men's-health adjacencies — TRT, peptides, ED, anti-aging — on one account
• Transparent published pricing with no insurance required

Against it

• Tirzepatide is billed quarterly at $249/month, so each renewal is a single charge of roughly $747
• Not available in eight states (AL, AR, CA, HI, ID, MI, NC, TX)
• Men's-only branding, which will not suit women seeking GLP-1 access
• The compounding pharmacy and the prescribing clinicians are not publicly named
• Compounded tirzepatide is not the FDA-approved branded product

In its favour

• No membership fee and no separate doctor fee — the monthly figure is the whole bill
• Both oral and injectable formats for semaglutide and tirzepatide
• HSA and FSA eligible
• Accepts patients transferring from an existing GLP-1 or TRT provider rather than making them restart
• Asynchronous consultations in most states, with no video visit required

Against it

• The advertised 'from $149/month' does not exist at checkout — the cheapest real plan is $175/month billed $525 up front
• Its own tier labelling is inconsistent: a 'high dose' and a 'low dose' tier both list 5 mg/week at $399 and $233 respectively
• State availability is not published, described only as 'most states'
• No visible LegitScript certification or PCAB accreditation
• Men's-only branding, and a newer brand with limited independent review coverage

In its favour

• Bundles the drug with a muscle-preservation supplement stack, addressing the lean-mass loss that comes with rapid weight loss
• The corporate entity is disclosed (LivBody Wellness, LLC), which many competitors will not do
• The $279 programme price includes consultation and ongoing provider support with no hidden visit fee
• Supplements ship from the same brand, so the bundle is genuinely one order

Against it

• $279 is a starting tier, not a flat rate — what a titrated dose costs is not published
• States served are not disclosed; you find out at checkout
• The pharmacy partner is named only as a 'US-licensed pharmacy', with no 503A or 503B designation given
• No LegitScript certification mentioned and no named medical director or clinical leadership
• Supplements are not a substitute for resistance training, which is the intervention the evidence actually supports

In its favour

• The consultation and free overnight shipping are included in the monthly price rather than billed separately
• Both compounded semaglutide and compounded tirzepatide, with a microdose option
• Tiered monthly pricing published from $199/month upward
• Cancel any time, with discreet shipping included

Against it

• FDA warning letter #717989, dated 20 February 2026 — read the letter at fda.gov rather than any summary of it
• Pricing is quoted 'as low as', so $224.25 is a floor and the price of a titrated dose is not published
• States served are not publicly disclosed and sit behind the signup intake
• Limited public information about the programme, the clinicians, or the compounding pharmacy
• Brand Mounjaro and Zepbound are listed at $1,400/month, far above LillyDirect self-pay vials

In its favour

• Available in all 50 states
• Both compounded semaglutide and compounded tirzepatide offered
• Competitively priced against the compounded market on the first order

Against it

• The $258 is a new-patient first-order rate on a six-month plan, not an ongoing monthly price
• The ongoing rate is not published anywhere and is disclosed only after intake
• Very little published information about the programme, the clinicians, or the compounding pharmacy
• Compounded tirzepatide is not the FDA-approved branded product

In its favour

• The operating legal entity is named (Dr. Hank, LLC), which most competitors will not disclose
• Three pharmacy partners disclosed by name rather than referred to generically
• Every tier is itemised on the product page — monthly, quarterly, six-month and yearly — with totals shown
• Free shipping and cancel-any-time terms stated up front

Against it

• Its own disclaimer claims compounded tirzepatide starts at $200/month; no $200 tier exists on any pricing card
• At $349 month-to-month it sits above the median for compounded tirzepatide — only the yearly commitment dips below it
• States served are not listed publicly
• GLP-1 is one of several verticals rather than the platform's focus
• No money-back guarantee or refund window is disclosed

In its favour

• LegitScript certified
• Unlimited telehealth visits and free shipping bundled into the monthly rate rather than billed as extras
• Both compounded semaglutide and compounded tirzepatide product lines
• The first-month price is published openly, with the compare-at rate shown alongside it

Against it

• The ongoing price after month one is not published — it could be flat at $239 or step up toward $379, and the site does not say
• Because no ongoing rate is confirmable, this entry is excluded from our price aggregates rather than assigned an assumed figure
• The legal entity name and state of incorporation are not disclosed
• The compounding pharmacy partner is not named and per-state availability is not listed
• Compounded only — no brand-name GLP-1 path

In its favour

• Names four US pharmacy partners — Triad Rx, Precision Medicine, RedRock Pharmacy and Beaker Pharmacy & Compounding
• Both compounded and brand-name (Wegovy, Zepbound) GLP-1 options on one platform
• Clinical oversight through the OpenLoop Health provider network and CareGLP affiliated practices
• Oral tablet and injectable formats offered on the semaglutide side

Against it

• No tirzepatide medication price is published at all — the $99 is a membership, and the drug is billed on top of it
• Compounded tirzepatide is no longer listed anywhere on the site; treat it as discontinued
• Not available in Mississippi or North Dakota, and five more states require a synchronous visit before prescribing
• Alabama and California patients can receive injectables only, not tablets
• No LegitScript or PCAB certification disclosed